Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith L Knutson

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Mayo Clinic Proceedings|January 4, 2012
Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinomaAbdirashid M Shire, Dalbir S Sandhu, Joseph K Kaiya, et al.
Cancer Research|June 19, 2008
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancerKimberly R Kalli, Christopher J Krco, Lynn C Hartmann, et al.
Breast Cancer Research and Treatment|November 15, 2022
Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriersJoshua Ogony, Tanya L Hoskin, Melody Stallings-Mann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2018
Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer PatientsKimberly R Kalli, Matthew S Block, Pashtoon M Kasi, et al.
Breast Cancer Research : BCR|June 15, 2018
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancerNadine Norton, Nicholas Fox, Christie-Ann McCarl, et al.
Frontiers in Immunology|August 16, 2023
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patientsZesheng An, Gabriel Figueroa-Parra, Xian Zhou, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patientsZesheng An, Xian Zhou, Yanfeng Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102Lavakumar Karyampudi, Courtney Formicola, Courtney L Erskine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2019
Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope VaccineKeith L Knutson, Matthew S Block, Nadine Norton, et al.
Breast Cancer Research and Treatment|November 2, 2017
CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changesDaniel Kerekes, Daniel W Visscher, Tanya L Hoskin, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Mayo Clinic Proceedings|January 4, 2012
Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinomaAbdirashid M Shire, Dalbir S Sandhu, Joseph K Kaiya, et al.
Cancer Research|June 19, 2008
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancerKimberly R Kalli, Christopher J Krco, Lynn C Hartmann, et al.
Breast Cancer Research and Treatment|November 15, 2022
Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriersJoshua Ogony, Tanya L Hoskin, Melody Stallings-Mann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2018
Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer PatientsKimberly R Kalli, Matthew S Block, Pashtoon M Kasi, et al.
Breast Cancer Research : BCR|June 15, 2018
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancerNadine Norton, Nicholas Fox, Christie-Ann McCarl, et al.
Frontiers in Immunology|August 16, 2023
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patientsZesheng An, Gabriel Figueroa-Parra, Xian Zhou, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patientsZesheng An, Xian Zhou, Yanfeng Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102Lavakumar Karyampudi, Courtney Formicola, Courtney L Erskine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2019
Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope VaccineKeith L Knutson, Matthew S Block, Nadine Norton, et al.
Breast Cancer Research and Treatment|November 2, 2017
CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changesDaniel Kerekes, Daniel W Visscher, Tanya L Hoskin, et al.
Pageof 15